​

Funding Round

Series A - Neuroglee Therapeutics

Series A - Neuroglee Therapeutics

Investment Firm

Overview

Neuroglee Therapeutics is a digital therapeutic platform created to treat patients in the early stages of the disease.

Announced Date

Sep 09, 2021

Funding Type

Series A

Highlights

Location

Asia

Social

Investor Lead

EDBI

EDBI

EDBI is a early_stage_venture and late_stage_venture and seed firm.

Openspace

Openspace

Openspace is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

6

Investor Name
Participant InvestorWendou Niu
Participant InvestorKuldeep Singh Rajput
Participant InvestorEisai
Participant InvestorOpenspace
Participant InvestorEDBI

Round Details and Background

Neuroglee Therapeutics raised $10000000 on 2021-09-09 in Series A

Neuroglee Therapeutics is a digital therapeutic platform created to treat patients in the early stages of the disease.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 03, 2020
Pre Seed Round - Neuroglee Therapeutics
2-2.3M
Sep 09, 2021
Series A - Neuroglee Therapeutics
6-10.0M

Recent Activity

There is no recent news or activity for this profile.